Figure legends
Figure 1. Patients with VKC in the active phase (group A)
showed significant decrease of tear sCD14 and conjunctival CD14
expression when compared with healthy subjects and with patients with
VKC in the quiescent phase (group Q) and after VKC recovery (group R). *
= statistical significant vs healthy group; § = statistical significant
vs VKC in the quiescent phase (group Q); Ç = statistical significant vs
VKC recovery (group R).
Figure 2 Changes of expression of conjunctival TLR-4 and TLR-9
in patients with VKC in the active (A) and quiescent (Q) phases of the
disease and after VKC recovery (R) compared with healthy controls. * =
statistical significant vs healthy group; § = statistical significant vs
VKC in the quiescent phase (group Q); Ç = statistical significant vs VKC
recovery (group R).
Figure 3 Changes of expression of tear sCD14 and conjunctival
CD14, TLR-4 and TLR-9 in patients with VKC in the active phase, 7 days
after topical treatment with Hydrocortisone eye drops. * = statistical
significant vs baseline.